Deubiquitinating enzymes (DUBs) play an important role in the ubiquitin-proteasome system (UPS) by eliminating ubiquitins from substrates and inhibiting proteasomal degradation. Protein phosphatase methylesterase 1 (PME-1) inactivates protein phosphatase 2A (PP2A) and enhances the ERK and Akt signaling pathways, which increase cell proliferation and malignant cell transformation. In this study, we demonstrate that USP36 regulates PME-1 through its deubiquitinating enzyme activity. USP36 increases PME-1 stability, and depletion of USP36 decreases the PME-1 expression level. Furthermore, we demonstrate that USP36 promotes the ERK and Akt signaling pathways. In summary, it is suggested that USP36 regulates PME-1 as a DUB and participates in the ERK and Akt signaling pathways.
Deubiquitinating enzymes (DUBs) play an important role in the ubiquitin-proteasome system (UPS) by eliminating ubiquitins from substrates and inhibiting proteasomal degradation. Protein phosphatase methylesterase 1 (PME-1) inactivates protein phosphatase 2A (PP2A) and enhances the ERK and Akt signaling pathways, which increase cell proliferation and malignant cell transformation. In this study, we demonstrate that USP36 regulates PME-1 through its deubiquitinating enzyme activity. USP36 increases PME-1 stability, and depletion of USP36 decreases the PME-1 expression level. Furthermore, we demonstrate that USP36 promotes the ERK and Akt signaling pathways. In summary, it is suggested that USP36 regulates PME-1 as a DUB and participates in the ERK and Akt signaling pathways.
Keywords: Akt signaling pathway; deubiquitinating enzyme; ERK signaling pathway; Malignant transformation; ubiquitination; USP36 Ubiquitination, involved in post-translational modification (PTM), is a process in which ubiquitin binds to a target protein and regulates proteasomal degradation and function of the substrate protein [1] . There are seven lysine residues (K6, K11, K27, K29, K33, K48, and K63) on ubiquitin and polyubiquitin chains are formed on these residues [2] . Different types of polyubiquitin chains produce different outcomes of the target protein [3] . When K48-linked polyubiquitin chains are formed on target proteins, the 26S proteasome recognizes and destructs the polyubiquitinated proteins [4] . In contrast, K63-linked polyubiquitination modulates protein function including DNA repair and endocytosis but does not regulate proteasomal degradation [5, 6] . Deubiquitination counterbalances the ubiquitination and deubiquitinating enzymes (DUBs) participate in the process [7, 8] . DUBs cleave ubiquitin molecules from substrates and have various roles in cellular processes [9] . There are approximately 100 DUBs in the human genome and they have been grouped into two main classes: cysteine protease and metalloprotease [10] . The cysteine protease class contains ubiquitin-specific protease (USP), ubiquitin C-terminal hydrolase (UCH), ovarian tumor protease (OTU), MachadoJoseph disease protease (MJD), permutated papain fold peptidases of dsDNA viruses and eukaryote (PPPDE), and motif interaction with Ub-containing Novel DUB (MINDY1) family. The metalloprotease class is represented by the Jab1/Pab1/MPN metalloenzyme motif protease (JAMM) family [11] [12] [13] .
Protein phosphatase 2A (PP2A) is a tumor suppressor that inhibits malignant transformation and negatively regulates the ERK and Akt signaling pathways via dephosphorylating oncogenic molecules including Abbreviations DUB, deubiquitinating enzyme; JAMM, The metalloprotease is Jab1/Pab1/MPN metalloenzyme motif protease; MALDI-TOF/MS, Matrixassisted laser desorption/ionization time-of-flight mass spectrometry; MINDY1, motif interaction with Ub-containing Novel DUB; MJD, Machado-Joseph disease protease; OUT, ovarian tumor protease; PME-1, protein phosphatase methylesterase 1; PP2A, protein phosphatase 2A; PP2Ac, carboxy-terminal tail of the catalytic subunit of PP2A; PPPDE, permutated papain fold peptidases of dsDNA viruses and eukaryote; PTM, post-translational modification; UCH, ubiquitin C-terminal hydrolase; USP, ubiquitin-specific protease.
c-Myc, p53, MEK, and Akt [14] [15] [16] [17] . Methylation of the carboxy-terminal tail of the catalytic subunit of PP2A (PP2Ac) enhances both catalytic activity of PP2Ac and recruitment of the specific B subunit to the PP2A complex [18] . In contrast, removal of the methyl group is catalyzed by protein phosphatase methylesterase 1 (PME-1) [19] . PME-1 inactivates PP2A, increases proliferation, and promotes malignant cell growth of human glioblastoma cells [19, 20] . Although a tumorpromoting mechanism involving PME-1 has been reported, regulation of PME-1 in cancer induction and progression remains to be elucidated. Herein, we demonstrate that USP36 increases the stability of PME-1 through deubiquitination and enhances ERK and Akt signaling pathways. Therefore, our results suggest that USP36 might promote cancer progression through the ERK and Akt signaling pathways.
Materials and methods

Construction of expression vectors
The cDNA of full-length USP36 and USP36 (C131S) was described previously [21] . For glutathione S-transferase (GST) pull-down assay, the full-length PME-1 was cloned into pGEX4T-1 plasmid vector. The shRNA constructs for USP36 were produced using the pSilencer 1.0-U6 vector. The target sequences of USP36 are 5 0 -GAG AGA GAA GAG GAG AAA CTT-3 0 for USP36 shRNA#1, 5 0 -GAG AGA AGA GGA GAA ACT TCA-3 0 for USP36 shRNA #2, and 5 0 -ACT TCA GAC TCG ACG GAA CTT C-3 0 for USP36 shRNA #3. PME-1-mutated constructs (K121R, K206R, K273R, and K296R) were generated for ubiquitination assay. The forward primers (5 0 -AAC AAA GGT CAG GAA TCCT GAA , and 296 of PME-1 with an arginine, respectively. After conduction of PCR, Dpn I (Enzynomics, Daejeon, Korea) enzyme was added to the PCR product. The mutants of PME-1 (K121R, K206R, K273R, and K296R) were confirmed by direct sequencing (Cosmogenetech, Seoul, Korea).
Cell culture conditions, transfection, and siRNA transfection 
GST pull-down assay
To perform the GST pull-down assay, GST-PME-1 was induced with 0.2 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) (Promega, Madison, WI, USA) at 26°C for 15 h. Purified GST-PME-1 from E. coli BL21 (DE3) was incubated with GST Bind Agarose Beads (ElpisBio, Deajeon, Korea) at 4°C overnight. The bound proteins were washed with a washing buffer (0.1 M Tris-HCl at pH 7.4, 0.5 M NaCl, 20 mM imidazole at pH 7.4). Then, it was boiled with 2 9 SDS buffer and then used for western blotting with an anti-Myc antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Western blotting and Immunoprecipitation
Cells were washed with PBS and lysed with a lysis buffer (50 mM Tris-HCl [pH 7.5], 300 mM NaCl, 1 mM EDTA, 10% Glycerol, 1% Triton X-100 
Immunocytochemistry
293T and HeLa cells were seeded on glass coverslips placed on a 12-well plate. The cells were fixed with 4% formaldehyde for 1 min and were blocked with PBS containing 2% normal goat serum and 1% triton X-100 for 1 h at room temperature. The cells were incubated with primary antibodies overnight at 4°C. Then, cells were washed with PBS and incubated with Alexa-Fluor-488-cojugated goat anti-mouse (1 : 100, Invitrogen, Carlsbad, CA, USA) and goat anti-rabbit 1 : 100, Invitrogen, Carlsbad, CA, USA) for 1 h at room temperature. The samples were visualized with a fluorescence microscope.
Ubiquitination and deubiquitination assays
To identify ubiquitination sites of PME-1, mutant constructs of PME-1 were generated. The ubiquitination sites were predicted by BDM-PUB, Ubpred, CKSAAP, and UbiProber databases [22] [23] [24] [25] . For the ubiquitination assay of PPME1, 293T cells were transfected with HA-ubiquitin and FLAG-PME-1 with 150 mM NaCl and 10 mM polyethylenimine (PEI, Polysciences, Inc., Warrington, PA, USA). Then, cells were incubated for 48 h and MG132 was treated for 4 h before harvest. The incubated cells were lysed in a lysis buffer (20 mM Tris-HCl at pH 7.5, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 100 mM PMSF and protein inhibitor cocktail). For immunoprecipitation analysis, lysed cells were incubated with an anti-FLAG (Sigma-Aldrich, St. Louis, MO, USA) antibody at 4°C overnight. Then, protein A/G Agarose Beads (Santa Cruz Biotechnology, CA, USA) were added and incubated at 4°C for 2 h. Then, the agarose beads were washed and disported by boiling with 2 9 SDS buffer. The samples were used for western blotting with an anti-HA antibody (1 : 1000, Roche, Basel, Switzerland).
Deubiquitination assay was performed with HA-ubiquitin, Flag-PME-1 and Myc-USP36. MG132 was treated for 4 h before harvest. An anti-FLAG antibody (SigmaAldrich, St. Louis, MO, USA) was used to precipitate proteins and the samples were analyzed by western blotting. Ubiquitination level was detected by an anti-HA antibody (1 : 1000, Roche, Basel, Switzerland).
Statistical analysis
All experiments were performed at least three times. ImageJ (National Institutes of Health, Bethesda, MD, USA) was used for densitometric analysis. GraphPad Prism version 5 (GraphPad Software, La Jolla, CA, USA) was used to perform t-test. One-way analysis of variance followed by Tukey's multiple comparisons post hoc test was performed using GraphPad Prism version 5. *P < 0.05, **P < 0.01, and ***P < 0.001 were considered to indicate a statistically significant difference.
Results
USP36 binds to PME-1
By using 2-dimensional gel electrophoresis (2-DE) and Matrix-assisted laser desorption/ionization time-offlight mass spectrometry (MALDI-TOF/MS) analysis, we previously identified proteins that were regulated by USP36 [26] . Those previous data showed that PME-1 has high score and was upregulated compared to control expression [26] . To validate those data, the interaction between USP36 and PME-1 was checked through immunoprecipitation analysis. In the present study, 293T cells were transfected with Myc-USP36 and FLAG-PME-1 and immunoprecipitated with either anti-Myc or anti-FLAG antibodies. The results showed that USP36 binds to PME-1 (Fig. 1A) . We also conducted immunoprecipitation assays using anti-USP36 or anti-PME-1 antibodies to examine endogenous protein binding between USP36 and PME-1 (Fig. 1B) . In addition, we performed GST pull-down assay with GST fusion protein GST-PME-1. GST-PME-1 was incubated with 293T whole cell lysates with overexpressed Myc-USP36 and the binding proteins were analyzed by western blotting. The results indicated that GST-PME-1 binds to Myc-USP36, confirming an interaction between USP36 and PME-1 (Fig. 1C) . Thus, interaction between USP36 and PME-1 was demonstrated. It has been known that USP36 is predominately localized at the nucleolus and PME-1 is mainly localized in the nucleus [27] [28] [29] . We observed that USP36 is largely localized at the nucleolus and PME-1 is localized at the nucleolus and in the nucleus. Immunoprecipitation analysis between USP36 and PME-1 was conducted with either anti-USP36 or anti-PME-1 antibodies. (C) GST-PME-1 was obtained from BL21 and immobilized to glutathione sepharose beads. GST-PME-1 was incubated with 293T cells transfected with Myc-USP36. GST-PME-1 was stained by Coomassie brilliant blue. Bound proteins were confirmed by western blotting with an anti-Myc antibody.
(D) Immunochemical staining was performed to investigate the colocalization of USP36 and PME-1 in 293T and HeLa cells.
Immunocytochemical analysis revealed that USP36 and PME-1 were colocalized at the nucleolus of 293T and HeLa cells (Fig. 1D) .
PME-1 interacts with all domains of USP36
To identify the USP36-binding site for PME-1, deletion forms of Myc-USP36 were generated ( Fig. 2A) . We cointroduced Myc-USP36 or deletion mutants of Myc-USP36 and FLAG-PME-1 into 293T cells and undertook immunoprecipitation analyses between deletion forms of USP36 and the full-length PME-1. The full-length PME-1 bound to all deletion forms of USP36 (Fig. 2B) . Reciprocal immunoprecipitation analyses were performed and the results showed that all deletion forms of UPS36 interact with the fulllength PME-1 (Fig. 2B) .
PME-1 is regulated by the ubiquitin-proteasome pathway
To determine whether PME-1 undergoes ubiquitination, 293T cells were transfected with FLAG-PME-1 and HA-ubiquitin, and ubiquitination assay of PME-1 was performed. The assay results demonstrated that PME-1 was ubiquitinated and the ubiquitination level of PME-1 was increased by MG132, indicating that PME-1 is regulated by the UPS (Fig. 3A, lanes 2 and  3) . K48-and K63-linked polyubiquitinations of PME-1 were also checked by using K48-and K63-specific Relative expression levels of Ub-PME-1
HA-Ub
FLAG-PME-1 Fig. 3 . PME-1 is regulated by the UPS. (A) 293T cells were transfected with FLAG-PME-1 and mutants of HA-ubiquitin (R48K and R63K).
The asterisks indicate the immunoglobulin heavy chain. (B) Location of lysine residues of PME-1, which were predicted ubiquitination sites. These lysine residues were replaced with arginine by site-directed mutagenesis. (C) 293T cells were transfected with mutant constructs of FLAG-PPME1 (K121R, K206R, K273R, and K296R) and HA-ubiquitin (n = 3, * for P < 0.05, ** for P < 0.01, *** for P < 0.001).
ubiquitin mutant constructs (R48K and R63K), and K48-and K63-linked polyubiquitin chains were formed on PME-1 (Fig. 3A, lanes 4 and 5) . In addition, we determined which lysine residue of PME-1 is involved in the ubiquitination process. Ubiquitination is a process in which the C-terminal ubiquitin binds to a lysine residue on the target proteins [30] . Thus, we generated four types of mutant FLAG-PME-1 by sitedirected mutagenesis (K121R, K206R, K273R, and K296R) (Fig. 3B) . Each ubiquitination site (K121, K206, K273, and K296) showed high ubiquitination scores on ubiquitination prediction websites. Thus, ubiquitination assays were conducted using the mutant FLAG-PME-1 constructs. We observed that the ubiquitination level of PME-1 was inhibited in 293T cells transfected with the K273R site, suggesting that PME-1 is ubiquitinated mainly through the K273 residue on PME-1 (Fig. 3C ).
USP36 has DUB activity for PME-1
Based on the result showing binding between USP36 and PME-1, we assessed the functional interaction between USP36 and PME-1. To determine whether ubiquitination of PME-1 is regulated by USP36, deubiquitination assay was performed using wild-type Myc-USP36 and a catalytically inactive mutant Myc-USP36 (C131S). The ubiquitination level of PME-1 was decreased by wild-type Myc-USP36; however, Myc-USP36 (C131S) did not suppress the ubiquitination level of PME-1 (Fig. 4A) . We also performed a DUB assay using shUSP36 to confirm the presence of specific DUB activity of USP36 on PME-1. By performing western blotting, we accessed whether shUSP36 downregulates USP36 (Fig. 4B) . We generated three types of shUSP36s, and shUSP36 #3 showed the highest knockdown efficiency (data not shown) and was therefore used for subsequent experiments. 293T cells were transfected with FLAG-PME-1 and shUSP36. The result showed that the ubiquitination level of PME-1 is increased with shUSP36 (Fig. 4C) . Furthermore, we investigated the ubiquitination of PME-1 by siUSP36. We checked knockdown efficiency of siUSP36s and selected siUSP36#3 shown the best efficiency for further experiments (Fig. 4D) . We observed that downregulation of USP36 increases the ubiquitination level of PME-1 (Fig. 4E) , indicating that USP36 regulates PME-1 for deubiquitination. We observed that PME-1 formed polyubiquitin chains through K48 and K63 (Fig. 3A) . Thus, we determined whether USP36 deubiquitinates K48-and K63-linked polyubiquitination of PME-1. 293T cells were transfected with HA-ubiquitin, Myc-USP36, and FLAG-PME-1. The FLAG-PME-1 was then immunoprecipitated and the ubiquitination level was analyzed by K48-and K63-specific antibodies. Both K48-and K63-linked PME-1 polyubiquitination were decreased by USP36 (Fig. 4F,G) . Thus, USP36 regulates PME-1 as a DUB, and K48-and K63-linked polyubiquitination of PME-1 is deubiquitinated by USP36.
USP36 promotes ERK and Akt signaling pathways by stabilizing PME-1
DUBs play an important role in the UPS by removing polyubiquitin chains from target proteins and suppressing proteasomal degradation of substrates. We identified that USP36 regulates PME-1 as a DUB (Fig. 4A,  C) ; therefore, we investigated the effect of USP36 on the stability of PME-1. Myc-USP36 was overexpressed in HeLa cells and the expression level of PME-1 was analyzed. The expression level of PME-1 was upregulated with overexpression of Myc-USP36 (Fig. 5A ). To confirm the effect of USP36 on the stability of PME-1, we checked the effect of siUSP36 on PME-1 stability and observed that the expression level of PME-1 was decreased by USP36 knockdown (Fig. 5B) , suggesting that PME-1 stability is regulated by USP36.
It was previously demonstrated that PME-1 activates the ERK and Akt signaling pathways by inhibiting PP2A and enhances cellular proliferation and malignant cell transformation [20, [31] [32] [33] . We demonstrated that USP36 regulates PME-1 stabilization, thereby we investigated whether knockdown or overexpression of USP36 affects the ERK and Akt signaling pathways. As expected, knockdown of USP36 inhibited phosphorylation of ERK (Fig. 5B) . It has been reported that PP2A inhibits Akt signaling pathway by dephosphorylating Akt at Thr308 [34] , and we observed that phosphorylation of Akt (Thr308) was decreased by PME-1 (Fig. 5B) . Moreover, overexpression of Myc-USP36 increased ERK and Akt phosphorylation, indicating that USP36 has a role in activation of ERK and Akt signaling pathways (Fig. 5C ). To investigate whether USP36 regulates ERK and Akt signaling pathways by increasing PME-1 stability, we checked the knockdown efficiency and selected siPME-1#2 for the experiment (Fig. 5D) . Then, we analyzed whether siPME-1 inhibits ERK and Akt signaling pathways induced by overexpression of USP36 in HeLa cells. Whereas overexpression of PME-1 or USP36 induces the expression level of pERK and pAkt in the cells, phosphorylation of these proteins was inhibited by siPME-1 (Fig. 5E) . It is suggested that USP36 regulates ERK and Akt signaling pathways by modulation of PME-1.
Discussion
DUBs are able to reverse ubiquitination by detaching ubiquitins from target proteins, and they regulate various cellular functions including apoptosis, proliferation, and cell survival by participating in various signaling pathways. Therefore, it is important to investigate and describe the regulation of DUB activities on target proteins for maintaining cellular homeostasis. USP36 belongs to the USP family of DUBs Relative expression levels of Ub-PME-1 *** ** Fig. 4 . USP36 deubiquitinates PME-1. (A) FLAG-PME-1, Myc-USP36, Myc-USP36 (C131S), and HA-ubiquitin were transfected into 293T cells. (B) The knockdown efficiency of shUSP36 was checked by western blotting in 293T cells. (C) 293T cells transfected with FLAG-PME-1, HA-ubiquitin and increasing concentrations of shUSP36. The ubiquitination level of PME-1 was determined by western blotting. (D) To check knockdown efficiency of siUSP36s, we performed transfection of the constructs into 293T cells and the efficiency was determined by western blotting. (E) HA-ubiquitin and siUSP36 were cotransfected into 293T cells and the ubiquitination level of PME-1 was observed.
(F) FLAG-PME-1, Myc-USP36, and HA-ubiquitin were transfected into 293T cells. The expression level of K48-linked polyubiquitination was determined by using anti-K48 antibody. (G) FLAG-PME-1, Myc-USP36, and HA-ubiquitin (K63R) were overexpressed in 293T cells. Anti-K63 antibody detected K63-linked polyubiquitination of PME-1. The asterisks indicate the immunoglobulin heavy chain (n = 3, * for P < 0.05, ** for P < 0.01, *** for P < 0.001).
and has PEST motifs that are responsible for polyubiquitination [21] . It has been reported that USP36 deubiquitinates and stabilizes the transcription factor c-Myc, which is upregulated in cancer [35] . Upregulation of USP36 is observed in breast and lung cancer cells [35] . In addition, USP36 increases the half-life of superoxide dismutase 2 (SOD2), which is a key mitochondrial antioxidant enzyme [26] . In a previous 2-DE and MALDI-TOF/MS study, we investigated proteins that might be regulated by USP36. In that study, it is suggested that USP36 may enhance the stability of PME-1. Therefore, we first analyzed an interaction between USP36 and PME-1 by performing immunoprecipitation and GST pull-down assays (Fig. 1A-D) , and demonstrated that USP36 interacts with PME-1, suggesting that PME-1 is regulated by USP36. To determine which domain of USP36 binds to PME-1, we generated three deletion mutants of the USP36 including USP domain (1-423 aa), the central domain (424-766 aa), and the C-terminal nucleolar localization signal (NoLS)-containing domain (767-1125 aa) [27] . We observed that all deletion mutants of USP36 bind with the full-length PME-1 ( Fig. 2A) . The USP domain is involved in cleavage of isopeptide bonds To examine the effect of USP36 on stability of PME-1, Myc-USP36 was transfected into HeLa cells. Western blotting was performed by using anti-Myc and anti-PME-1 antibodies. (B) siUSP36 was transfected into HeLa cells and the expression levels of PME-1, pERK, and pAkt were investigated. (C) To check the effects on ERK and Akt signaling pathways, phosphorylation of ERK and Akt was determined. (D) siPME-1s were transfected into 293T cells to determine knockdown efficiency of the constructs. (E) HeLa cells were transfected with Flag-PME-1, Myc-USP36, and siPME-1, and phosphorylation of ERK and Akt was checked (n = 3, * for P < 0.05, ** for P < 0.01, *** for P < 0.001). [8] . It has been reported that USP36 mainly functions at the nucleoli, and we showed that USP36 interacts with PME-1 for deubiquitination (Fig. 4A,C and E) , suggesting that the USP domain of USP36 might bind to PME-1 for deubiquitination at the nucleoli [27] . The central domain of USP36 might have a nuclear localization signal (NLS), which induces the protein to be imported into the nucleus [27, 36] . It has been reported that USP4, which has NLS, interacts with b-catenin and a mutant of USP4 lacking NLS inhibits nuclear transport of b-catenin as well as USP4 [37] . PME-1 is mainly localized in the nucleus and weakly in the cytosol [29, 38] . It is possible that USP36 regulates nuclear transport of PME-1. The C-terminal region of USP36 contains NoLS which is required to be localized at the nucleoli, and USP36 lacking the C-terminal leads to mislocalization of USP36 in the nucleoplasm [27] . We observed that both USP36 and PME-1 were localized at the nucleoli (Fig. 1D) , suggesting that PME-1 might interact with the C-terminal region of USP36 for nucleolar localization. Taken together, all domains of USP36 might be required to efficiently regulate PME-1 in the nucleus.
An elevated level of PME-1 gene expression has been observed in a small portion of gastric and lung cancer patients; however, the expression level of PME-1 has been correlated with a favorable clinical outcome in colon cancer patients [39, 40] . Moreover, PME-1 protein is overexpressed in glial tumors and has a role in endometrial cancer aggressivity [20, 41] . Therefore, as PME-1 is related to several types of cancers, we investigated the functional interaction between USP36 and PME-1 to identify the role of USP36 on the target protein. Initially, we observed that PME-1 undergoes ubiquitination, and the K273 residue of PME-1 is mainly ubiquitinated (Fig. 3A,C) . Subsequently, DUB assays indicated that overexpression of USP36 decreased the ubiquitination levels of PME-1, and a mutant form of USP36 without DUB activity could not regulate ubiquitination of PME-1, suggesting that USP36 interacts with PME-1 as a DUB (Fig. 4A) . Also, inhibition of USP36 expression using shUSP36 increased the ubiquitination level of PME-1 (Fig. 4C,D) .
PP2A, a serine/threonine phosphatase, is a tumor suppressor, and inactivation of PP2A is related to solid and hematological tumors [42, 43] . Inactivation of PP2A is induced by PME-1, which suppresses the ERK and Akt signaling pathways. The ERK and Akt signaling pathways are important signal transduction processes for inducing cell proliferation and survival, and essential mediators in the activation of oncogenic pathways. Mutations of genes that encode factors involved in the ERK and Akt signaling pathways can give rise to an increase in cancer frequency. In this study, we observed that USP36 increases the expression level of PME-1 through K48-linked polyubiquitination ( Fig. 3A and 5A ), whereas the inhibition of USP36 decreases the expression level of PME-1 (Fig. 5B) . Based on these results, we investigated the effect of USP36 on the ERK and Akt signaling pathways. Phosphorylation of ERK and Akt was increased by USP36 as expected (Fig. 5C ), indicating that USP36 might regulate these signaling pathways. Thereby, we checked whether the knockdown of PME-1 inhibits these USP36-inducing signaling pathways. When the expression level of PME-1 was decreased, phosphorylation of ERK and Akt was not increased in spite of overexpression of USP36 (Fig. 5E ).
In conclusion, we have demonstrated that USP36 regulates PME-1 as a DUB and USP36 promotes the ERK and Akt signaling pathways. Therefore, inhibition of USP36 might be an alternative therapeutic strategy for decreasing proliferation and survival of cancer cells.
